Visual Universitätsmedizin Mainz

Competitive grants

Current Grants

 

  • BASF SE: “Enzymatic Inactivation of Amylase/Trypsin Inhibitors from Wheat”. Role: PI: 08/01/2016 – 10/31/2016.
      
  • German Research Foundation (DFG): Collaborative Research Center, CRC SFB TR 128/2; ,Initiating/effector versus regulatory mechanisms in Multiple Sclerosis – progress towards tackling the disease‘  (Münster/Mainz): „Impact of dietary factors on the gut-CNS-axis – implication for CNS autoimmunity“. Role: PI with PD Dr. Luisa Klotz, University Hospital Münster: 07/01/2016 – 06/30/2020.
     
  • German Research Foundation (DFG): Priority Programme SPP 1656; ‚Intestinal Microbiota – a microbial ecosystem at the edge between immune homeostasis and inflammation‘: “Functional consequences of intestinal microbiota altered ingestion of gluten and wheat alpha-amylase-trypsin inhibitors”. Role: PI: 06/01/2016 – 05/31/2019.
     
  • German Research Foundation (DFG): “ Wheat sensivity”: Impact of wheat varieties and growing conditions on innate immunity“. Role: PI: 06/01/2016 – 05/31/2019.
     
  • Pronova BioPharma AS: „Evaluation on the modified fatty acid SEFA 3002 as treatment for the inflammatory and fibrotic pathologies of nonalcoholic steatohepatitis in two complementary optimized mouse models”. Role: PI: 05/01/2016 – 04/30/2017.
     
  • Leibniz Association: “WHEATSCAN – Identify the causes of wheat Intolerances“. Role: PI: 04/01/2016 – 03/31/2019.
     
  • German Ministry of Education and Research (BMBF), CI3 Cluster for Individualized Immune Intervention (with Zedira, Pharma, Falk Pharma): “Clinical Development of Transglutaminase-Inhibitors for the Treatment of Celiac Disease”. Phase 2. Role: Co-PI: 10/01/2015 – 03/31/2017.
    http://www.ci-3.de/en
     
  • Software AG Foundation: „Consideration the amylase trpsin inhibitors (ATI) in wheat cultivation“. Role: PI: 10/01/2015 – 09/31/2016.
     
  • German Research Foundation (DFG): Collaborative Research Center TRR 156; ‚The Skin as Sensor and Initiator of Local and Systemic Immune Reactions‘ (Heidelberg/Tübingen/Mainz): “Scleroderma: The role of macrophages and dendritic cells in tissue fibrosis“. Role: PI, with Prof. K.  Steinbrink, Dermatology: 07/01/2015 – 06/30/2019.
    https://www.klinikum.uni-heidelberg.de/SFB-TRR156.138143.0.html?&L=0
     
  • H2020-PHC-2014 (EU): “Elucidating Pathways of Steatohepatitis”. Role: Co-PI (PI Biomarkers, Co-PI: patient samples). 05/01/2015 – 04/30/2019.
    http://www.epos-nafld.eu/
    EpoS Flyer (Pdf-file, 4,6 MB)
    Pressrelease EPoS (Pdf-file, 75,6 KB)
     
  • ZonMW: „Use of human and animal tissue slices for the development of antifibrotic compounds“, Cooperation with the University of Groningen; 09/01/2014 – 08/31/2018.
     
  • German Research Foundation (DFG): Collaborative Research Center, SFB 1066; ‚Nanodimensional Therapeutics for Cancer Therapy‘: “Therapy of metastatic melanoma by addressing tolerance inducing macrophages“.  Role: PI, with Dr. A. Tüttenberg, Dermatology: 10/01/2013 – 06/30/2017.
    http://www.blogs.uni-mainz.de/crc1066/
     
  • ERC Advanced Grant „Quantitative Imaging of Liver Fibrosis and Fibrogenesis“.
    Role: PI: 08/01/2012 – 07/31/2017.

 

Completed projects: Please click here!